 |
|
|
| |
Epidemiologic Impact of Expanding Chronic Hepatitis C (CHC) Treatment in People Who Inject Drug in the United States: A Mathematical Model Using Data From the C-EDGE CO-STAR Study
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017; Washington, DC, USA; October 20-24, 2017.
Yiling Jiang1; Chizoba Nwankwo2
1Merck Sharp & Dohme Ltd., Hoddesdon, Hertfordshire, UK;
2Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
